The efficacy and safety of omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the
prevention of atrial fibrillation (AF) is a source of ongoing debate in the current literature …

Many physicians recommend the use of fish oil or omega-3 polyunsaturated fatty acids (n-3
PUFA) in atrial fibrillation (AF) patients. N-3 PUFA have demonstrated anti-fibrillatory …

Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting more than 2.6 million
people in the United States. It occurs frequently after myocardial infarction and is the most …

Background: The main dietary source of omega-3 polyunsaturated fatty acids (n-3 PUFA) is
fish, which contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the …

Atrial fibrillation (AF) is the most common sustained atrial arrhythmia conferring a higher
morbidity and mortality. Despite the increasing incidence of AF; available therapies are far …

Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical
practice with growing prevalence in developed countries. Several medical and …

Atrial fibrillation (AF) is the most prevalent arrhythmia and is associated with considerable
morbidity and mortality. Available pharmacologic antiarrhythmic therapies are often …

Atrial fibrillation (AF) is the most frequent type of cardiac arrhythmia that affects over six
million individuals in Europe. The incidence and prevalence of AF rises with age, and often …

Background Previous studies have suggested that n‐3 polyunsaturated fatty acids (n‐3
PUFA s) have antiarrhythmic effects on atrial fibrillation (AF). We aimed to assess the effects …

Marine n− 3 polyunsaturated fatty acids (PUFA) may have beneficial effects in relation to
atrial fibrillation (AF) with promising data from experimental animal studies, however, results …